| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |